Control of tumor progression by angiocrine factors

Tumor progression, therapy resistance and metastasis are profoundly controlled by the tumor microenvironment. The contribution of endothelial cells to tumor progression was initially only attributed to the formation of new blood vessels (angiogenesis). Research in the last decade has revealed howeve...

Full description

Saved in:
Bibliographic Details
Main Authors: Alsina Sanchis, Elisenda (Author) , Mülfarth, Ronja (Author) , Fischer, Andreas (Author)
Format: Article (Journal)
Language:English
Published: 26 May 2021
In: Cancers
Year: 2021, Volume: 13, Issue: 11, Pages: 1-14
ISSN:2072-6694
DOI:10.3390/cancers13112610
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cancers13112610
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6694/13/11/2610
Get full text
Author Notes:Elisenda Alsina-Sanchis, Ronja Mülfarth, Andreas Fischer
Description
Summary:Tumor progression, therapy resistance and metastasis are profoundly controlled by the tumor microenvironment. The contribution of endothelial cells to tumor progression was initially only attributed to the formation of new blood vessels (angiogenesis). Research in the last decade has revealed however that endothelial cells control their microenvironment through the expression of membrane-bound and secreted factors. Such angiocrine functions are frequently hijacked by cancer cells, which deregulate the signaling pathways controlling the expression of angiocrine factors. Here, we review the crosstalk between cancer cells and endothelial cells and how this contributes to the cancer stem cell phenotype, epithelial to mesenchymal transition, immunosuppression, remodeling of the extracellular matrix and intravasation of cancer cells into the bloodstream. We also address the long-distance crosstalk of a primary tumor with endothelial cells at the pre-metastatic niche and how this contributes to metastasis.
Item Description:Gesehen am 19.08.2021
Physical Description:Online Resource
ISSN:2072-6694
DOI:10.3390/cancers13112610